Member Info for ogm4

Monster RNS

4.89p

Please note:

"This approach can be used to treat up to 50 autoimmune diseases ("AutoIDs"), representing a major step forward in precision medicine."

Up to 50!....

4.49p paid now

Also big investors will start to come onboard now over the next few weeks - massive news!

Interviews out later this week I guess!

Absolutely groundbreaking RNS 5 mins ago!....

This is a key milestone just being announced!....

Deals anytime now!

"This combination makes P140 a unique and extremely valuable asset, particularly with the potential for 20 years of commercial exclusivity, and will add enormous traction to our current discussions with potential global partners of P140."

"The new patent filing provides the potential for 20 years of commercial exclusivity for both the diagnostic test and P140 therapy, positioning ImmuPharma as a leader in the next generation of autoimmune disease treatments."

20 years of commercial exclusivity

Massive news!

**** ImmuPharma Files Groundbreaking New Patent Application for P140: First-in-Class 'Immunormalizer' for Precision Diagnosis and Treatment of Autoimmune Diseases. ****

.

Flood gates have just been opened

Shackles are coming off...

Block buys arriving now

So Avacta's current mc that would be equivalent of a share price of around 46p for Immupharma if I calculate correctly, whilst you say they are still in phase I

On patent filing news I would expect the sp to rise quickly to 4-5-6p being conservative if not higher and might even surpass Q1 heights of 7p. Any commercial deals thereafter could propel the sp further upwards to 10-15-20p levels as minimum or even higher, who knows...

Another £10k trade at 2.29p at nearly day high